...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Month 10
2
Apr 14, 2017 08:49PM
6
Apr 15, 2017 03:16PM
3
Apr 16, 2017 03:49PM
4
Apr 16, 2017 05:19PM
3
Apr 16, 2017 07:16PM
2
Apr 16, 2017 08:15PM

Apr 18, 2017 10:55AM
3
Apr 18, 2017 12:08PM

Thanks BDAZ I was replying to SF about patients in the dose escalation phase 8 to 10 months agao.

tada 

Share
New Message
Please login to post a reply